Dabigatran Reversal Drug Holds Promise
from MedPage Today
While treatment with dabigatran among patients diagnosed with atrial fibrillation is known to reduce the risk of stroke, researchers said the long half-life of the anticoagulant concerns doctors when patients on the drug need other treatments. But a new medication may hold the key to reversing the bleeding complications.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063